These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3182341)

  • 21. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.
    Teoh M; Beveridge S; Wood K; Whitaker S; Adams E; Rickard D; Jordan T; Nisbet A; Clark CH
    Med Dosim; 2013; 38(1):18-24. PubMed ID: 22841937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
    Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Topometric and clinico-dosimetric aspects of the radiotherapy of cancer of the oropharynx].
    Choudkhuri FA; Vorob'eva LV
    Med Radiol (Mosk); 1988 Mar; 33(3):38-45. PubMed ID: 3352492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The severity of late rectal and recto-sigmoid complications related to fraction size in irradiation treatment of carcinoma cervix stage III B.
    Deore SM; Shrivastava SK; Viswanathan PS; Dinshaw KA
    Strahlenther Onkol; 1991 Nov; 167(11):638-42. PubMed ID: 1962277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313.
    Cox JD; Pajak TF; Marcial VA; Coia L; Mohiuddin M; Fu KK; Selim H; Rubin P; Ortiz H
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1191-5. PubMed ID: 2045293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.
    Pinto LH; Canary PC; Araújo CM; Bacelar SC; Souhami L
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):557-62. PubMed ID: 1869454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity.
    Kaanders JH; van Daal WA; Hoogenraad WJ; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 1992; 24(3):497-503. PubMed ID: 1399736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
    Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
    Yu E; Shenouda G; Beaudet MP; Black MJ
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems.
    Denis F; Garaud P; Bardet E; Alfonsi M; Sire C; Germain T; Bergerot P; Rhein B; Tortochaux J; Oudinot P; Calais G
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):93-8. PubMed ID: 12504040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alternating chemoradiotherapy for oropharyngeal cancer].
    Sasaoka M; Fuwa N; Matsumoto A; Kimura Y; Furutani K; Kamata M; Kodaira T; Morita K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2217-21. PubMed ID: 11142165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
    Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
    Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.